Imunon Inc (IMNN) support and resistance · rev $500.0K
Imunon Inc (IMNN) is a biotechnology company listed on US.
This page maps Imunon Inc (IMNN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.
IMNN currently screens at market cap $9.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMNN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMNN quote page for the session range and the stock page for the full model.
Not investment advice.